Prognostic Value of CSF Total Tau Protein in Patients with Familial and Sporadic Creutzfeldt-Jakob Disease
Dementia and Geriatric Cognitive Disorders · 05.03.2026 · 1-8
DOI: 10.1159/000551359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dementia and Geriatric Cognitive Disorders, online erschienen am 05.03.2026. Verfasst von Yacov Balash und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Kaplan Medical Center, Rehovot, Israel, yacovbalash@gmail.com. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Elevated total tau protein (t-τ) in the cerebrospinal fluid (CSF) is routinely used as a marker of Creutzfeldt-Jakob disease (CJD). We hypothesized that CSF t-τ and patients’ age may anticipate survival time (ST) also in subjects with familial CJD (f-CJD) as has been shown previously in sporadic CJD (s-CJD).
Methods
We analyzed data from the Israeli National CJD Registry from 1991 to 2022. The data included cases of both f-CJD and s-CJD in whom demographic data and CSF t-τ levels were measured, and the date of death was available. Using X-tile software, we determined the optimal cut-off points for continuous variables in survival analysis and found the cut-points for t-τ level and patients’ age.
Results
We analyzed data on 183 sequential CJD patients. The data included definite (n = 9), probable (n = 165), and possible (n = 9) CJD cases of whom 120 (61 males) were f-CJD (65.6%) and 63 (35 males) patients were s-CJD (34.4%). The cut-off value of CSF t-τ level was found to be 1,226 pg/mL. It separated ST into two groups, 105 days (interquartile ranges [IQR]: 59–305) in the lower group vs. 59 days (IQR: 29.5–147.5) in the higher, p = 0.0005. Cox analyses showed that for every 100 pg/mL increase in CSF t-τ, ST shortened by 3% in days (Exp β = 1.0003; 95% confidence interval: 1.0001–1.0005). Age had no direct prognostic value but correlated with CSF t-τ levels (rho = 0.243, p < 0.001).
Conclusions
Age and CSF t-τ levels above the cut-off value predict ST shortening in patients with both f-CJD and s-CJD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Kaplan Medical Center, Rehovot, Israel, yacovbalash@gmail.com.
- The Hebrew University of Jerusalem, Jerusalem, Israel, yacovbalash@gmail.com.
- Department of Neurology, Barzilai University Medical Center, Ashkelon, Israel.
- Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel.
- Department of Neurology, The Agnes Gipges Center for Human Neurogenetics, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
- Tel-Aviv Sourasky Medical Center, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Zitieren
APA
Balash, Y., Kahana, E., Rosenmann, H., Omer, N., Gilad, R., Eilam, A., Appel, S., & Korczyn, A. D. (2026). Prognostic Value of CSF Total Tau Protein in Patients with Familial and Sporadic Creutzfeldt-Jakob Disease. Dementia and Geriatric Cognitive Disorders, 1-8. https://doi.org/10.1159/000551359
Vancouver
Balash Y, Kahana E, Rosenmann H, Omer N, Gilad R, Eilam A, et al. Prognostic Value of CSF Total Tau Protein in Patients with Familial and Sporadic Creutzfeldt-Jakob Disease. Dementia and Geriatric Cognitive Disorders. 2026:1-8. doi:10.1159/000551359
BibTeX
@article{Balash2026,
author = {Balash, Yacov and Kahana, Esther and Rosenmann, Hanna and Omer, Nurit and Gilad, Ronit and Eilam, Anda and Appel, Shmuel and Korczyn, Amos D},
title = {Prognostic Value of CSF Total Tau Protein in Patients with Familial and Sporadic Creutzfeldt-Jakob Disease},
journal = {Dementia and Geriatric Cognitive Disorders},
year = {2026},
pages = {1--8},
doi = {10.1159/000551359}
}
EUVIMED